Previous Close | 143.71 |
Open | 144.08 |
Bid | 142.95 x 200 |
Ask | 143.48 x 100 |
Day's Range | 143.00 - 146.07 |
52 Week Range | 141.98 - 218.88 |
Volume | |
Avg. Volume | 842,658 |
Market Cap | 18.122B |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
It hasn't been the best quarter for Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders, since the share price...